ExploreIterate

Tony Coles

Chief Executive Officer and Chairperson of the Board of Directors

Tony Coles, M.D., was appointed chief executive officer of Cerevel Therapeutics in September 2019. He also serves as chairperson of the board of directors—a position he held since December 2018, shortly after the company’s formation.


Dr. Coles joins Cerevel Therapeutics from Yumanity Therapeutics, a company focused on discovering and developing potentially disease-modifying therapies for patients with Parkinson’s disease, Alzheimer’s, Amyotrophic lateral sclerosis, and other neurodegenerative disorders, where he served as chairperson and chief executive officer from 2014 to 2019. Dr. Coles is a co-founding investor and continues to serve as the executive chairperson of the board of directors of Yumanity Therapeutics. He is also chairperson and chief executive officer of TRATE Enterprises, LLC, a privately-held company.

Roles at Cerevel Therapeutics

  • Chief Executive Officer and Chairperson of the Board of Directors

    Current role


My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Cerevel Therapeutics

My pet peeves

My communication style